Navigation Links
New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
Date:11/27/2007

Dr. Jim Kim joins teleconference to release report with ITPC. Kim says foundations laid by AIDS response are "the best chance we've ever had to build comprehensive health systems in the poorest settings."

NEW YORK AND CAPE TOWN, South Africa, Nov.27 /PRNewswire-USNewswire/ -- The International Treatment Preparedness Coalition (ITPC), a group of 1,000 treatment activists from more than 125 countries, today issued its fifth report on scale up of AIDS services: Missing the Target #5: Improving AIDS Drug Access and Advancing Health Care for All. The report is available at http://www.aidstreatmentaccess.org.

The comprehensive report investigates AIDS drug access in 14 countries and finds that scale up is working but high prices, patent and registration barriers, and ongoing stock-outs are core issues impeding better and faster AIDS drug delivery.

"The foundations to make the 2010 target are in place in many countries. If governments, global agencies, and drug companies focus on tactically improving AIDS drug access by continually lowering costs, ending patent and regulatory problems, and fixing drug availability logistics, while simultaneously strengthening health systems, there is real possibility for making the 'near universal access' target by 2010," said Gregg Gonsalves, a coordinator of the project.

Missing the Target teams in nine countries -- Cambodia, Cameroon, China, Dominican Republic, India, Kenya, Russia, Zambia, and Zimbabwe -- also looked at broader issues in AIDS service delivery in their countries. "AIDS treatment scale up cannot succeed without stronger health systems, adequate nutrition, and concerted action against stigma and marginalization," said Matilda Moyo of the Zimbabwe research team.

"Mobilization around AIDS has opened up fantastic new possibilities in health service delivery by infusing new resources, intensifying the engagement
'/>"/>

SOURCE International Treatment Preparedness Coalition
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... DUBLIN , Nov. 26, 2014  Perrigo Company ... leading global provider of "Quality Affordable Healthcare Products®," today ... offering relating to the sale of 6,809,210 ordinary shares ... including the full exercise of the option to purchase ... Morgan Securities LLC and Barclays Capital Inc., as representatives ...
(Date:11/26/2014)... , Nov. 26, 2014   Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines targeting ... Ph.D., President and CEO of Regulus, will present a ... Jaffray Healthcare Conference at the New York Palace Hotel ... The presentation will be webcast at the time of ...
(Date:11/26/2014)... Scott Steiger lives in St. ... an engineer for the past 20 years, he,s traveled extensively and ... He,s been to six of the seven continents. Travel is a ... http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 So ... pretty good idea of what,s required. His latest creation ...
Breaking Medicine Technology:Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Steiger Has Created the First Pill Case Specifically Designed For Travel 2
... by experts to be important for cervical cancer ... data from an,extended follow-up study show that GlaxoSmithKline ... generates sustained high levels of,neutralizing antibodies against the ... up to 6.4 years. This is the longest,duration ...
... American Society of Hypertension,s Twenty-Third ... Annual Scientific Meeting - A cumulative ... a regimen of BENICAR(R) (olmesartan medoxomil), and BENICAR HCT(R) (olmesartan ... normotension (< 120/80 mm Hg) (placebo:1.4%)., - Eight out of ...
Cached Medicine Technology:CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 2CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 3CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 4CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 5CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 6New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 2New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 3New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 4New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 5New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 6New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 7
(Date:11/28/2014)... An inventor and dental assistant from Kent, Wash., ... and it was almost impossible to reach. "This gave me ... , The patent-pending Access Light allows for easier use of ... the mouth, as well as avoids harm to the lips, ... use and clean, it also helps prevent cross-contamination. , The ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 A newly ... provides an overview of the influenza virus that will soon ... season. , The article begins with a brief explanation ... its symptoms. It reminds families that children under the age ... suffering from chronic diseases, such as heart and lung diseases, ...
(Date:11/28/2014)... "Most of my life, I have suffered from ... an inventor from Findlay, Ohio. "I thought that there had ... foot, which inspired me to invent this accessory." , She ... to support an injured foot. The sling makes it easier ... for crutches. The design redistributes weight so that the individual ...
(Date:11/28/2014)... TN (PRWEB) November 28, 2014 ARTAS ... Tennessee for the first time. PAI Medical Group hair ... will be performing a robotic hair transplant procedure in ... 9:00 A.M. , The first in Tennessee and one ... Medical Group now offers ARTAS robotic hair transplantation. Patients ...
(Date:11/28/2014)... Nipomo Family Dentistry , founded ... opened its doors at 195 N. Thompson St., Suite ... care like teeth cleanings, oral exams, fillings, implants and ... whitening (and Kor whitening), laser whitening, gum tissue treatment, ... Dentistry’s five-person team also takes a philanthropic approach to ...
Breaking Medicine News(10 mins):Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 3
... choice of drug for patients suffering from prostate cancer may ... the Scottish Medicines Consortium (SMC) is of the view that ... much effect on prostate cancer making it an expensive not ... the drug feel that the drug had shown very good ...
... of the main causes of tooth loss worldwide and ... extractions (those with periodontal disease lost 2.8 teeth versus ... has now been found out from research that certain ... than others. ,The study analyzed the effects ...
... sinus tumors can be removed through the nose using endoscopy ... ,With this approach, doctors use tiny scopes and ... a device that pulverizes and suctions. At points where the ... and a diamond drill is used to eliminate tumor cells ...
... appears in the October issue of the journal ... early exposure to severe hypoglycemia during development negatively ... is a significant and relatively common complication of ... Repeated severe hypoglycemia has been reported to reduce ...
... Minister Anbumani Ramadoss has said that the government is very ... plans to take several steps to check female foeticide, which ... Ramadoss said that there were plans to set up surveillance ... practice that prevails on a large scale in the country. ...
... new research shows that in Children with neurological ... respiratory failure ,if they're hospitalized with influenza.// ... Journal of the American Medical Association, are based on ... influenza at The Children's Hospital of Philadelphia over four ...
Cached Medicine News:Health News:Nine Major Culprits For Tooth Loss Identified By Researchers 2Health News:Nine Major Culprits For Tooth Loss Identified By Researchers 3Health News:Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus 2Health News:Severe Hypoglycemia And Spatial Memory In Children With Type 1 Diabetes 2
... WideBiter Punch series facilitates fast and effective ... smooth, anatomically shaped meniscal rim. The flat, ... to access even the tightest joint spaces. ... Inc., 20 years of engineering experience in ...
... fast and effective resection of meniscal tears ... rim. The flat, crescent-shaped tip has an ... tightest joint spaces. Made in the U.S. ... engineering experience in arthroscopy hand instrument design ...
... The WideBiter Punch series facilitates fast ... recreating a smooth, anatomically shaped meniscal rim. ... low profile to access even the tightest ... Arthrex California, Inc., 20 years of engineering ...
... The WideBiter Punch series facilitates fast ... recreating a smooth, anatomically shaped meniscal rim. ... low profile to access even the tightest ... Arthrex California, Inc., 20 years of engineering ...
Medicine Products: